ArticleThe journal of allergy and clinical immunology. Global2025

Utility of serum biomarkers in real-world practice for predicting response to omalizumab therapy in patients with chronic spontaneous urticaria.

Wesley V Cain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.